Shervin Kamkar

Shervin Kamkar is a seasoned professional in business development and commercialization within the life sciences sector, currently serving as Vice President of Business Development at Kura Biotech since May 2022, overseeing the Blikka Genomics Division's market strategy and product development. Previously, Shervin held the position of Head of Strategic Partnerships at Roche, focusing on innovative OEM and custom solutions for next-gen sequencing. Other notable roles include Vice President of Business Development at Precision Medicine Advisors and strategic advisory positions at Doc.ai and Break Off. Shervin has a background in both commercial and account management, with significant experience at Illumina and Life Technologies, where contributions to the precision medicine and genomics fields were evident. Educational qualifications include multiple degrees in Molecular Biology from the University of California, San Francisco, and San Francisco State University, as well as a Bachelor's degree in Microbiology from UC Santa Barbara.